Notably, CDR C0 group was infiltrated with co-inhibitors and had higher expression of HAVCR2 than C2, C3, C4, providing sites for ICIs to combine and increasing anti-cancer CD8+ T cells immunity. The gene discussed is CD8A; the disease is cancer.